Research Article
The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia
Table 2
Medical history of all patients; patients can be counted more than once due to multimorbidity.
| | Medical history | | Tracheostomy | PDT | OST |
| | Patients | 63 | 21 | | Immunosuppression | 49 (77.8) | 11 (52.4) | | Hematological/oncological disease | 39 (61.9) | 7 (33.3) | | Acute leukemia | 15 (23.8) | 4 (19) | | Acute myeloid leukemia | 10 (15.9) | 3 (14.3) | | Acute lymphatic leukemia | 4 (6.3) | 1 (4.8) | | Lymphoma | 15 (23.8) | 1 (4.8) | | Non-Hodgkin’s lymphoma | 13 (20.6) | 1 (4.8) | | Hodgkin’s lymphoma | 1 (1.6) | — | | PTLD after lung transplant | 1 (1.6) | — | | Natural killer cell leukemia | 1 (1.6) | — | | Myelodysplastic syndrome | 4 (6.3) | 1 (4.8) | | Multiple myeloma | 4 (6.3) | 1 (4.8) | | Solid tumor | 3 (4.8) | 1 (4.8) | | lung transplantation | 2 (3.2) | 4 (19) | | COPD | 8 (12.7) | 3 (14.3) | | Mucoviscidosis | — | 2 (9.5) | | ARDS | 2 (3.2) | — | | Silicosis | 1 (1.6) | — | | Lung fibrosis | — | 1 (4.8) | | Pneumothorax | 1 (1.6) | — | | Hepatopathy | 1 (1.6) | — | | Cirrhosis of the liver | 3 (4.8) | 2 (9.5) | | Necrotizing pancreatitis | 1 (1.6) | — | | Mechanical ileus | 1 (1.6) | — | | Retention stomach | 1 (1.6) | — | | Gastrointestinal bleeding | 1 (1.6) | — | | Obesity | 1 (1.6) | 8 (38.1) | | Diabetes mellitus | 4 (6.3) | — | | Kidney transplantation | 2 (3.2) | — | | Meningococcal sepsis | — | 1 (4.8) | | Allogeneic stem cell transplantation | 16 (25.4) | 3 (14.3) | | Chimeric antigen receptor T cell therapy | 1 (1.6) | — |
|
|
The percentage refers to the total number of patients per group, so that multimorbidity can lead to more than 100%.
|
